Takeda Symposium

CIRTA Takeda logo

Furthering the evolution of SBS-IF management: The role of enterohormones

Thursday 01 July 2021, 05:30–06:30 (NZST)

Prof. Palle Jeppesen from Denmark and Dr Ulrich-Frank Pape from Germany will explore the use of enterohormone therapy in the management of patients suffering from short bowel syndrome due to intestinal failure (SBS-IF), including its position in the treatment algorithm and role in improving outcomes. They will share their clinical experience in the management of anatomically and clinically heterogeneous patients with SBS-IF, and present recent data and real-world evidence on enterohormone therapy. The presentations will be followed by a 15-minute Q&A session, where you can ask your questions of the esteemed panel.